Equities

REMSleep Holdings Inc

RMSL:PKC

REMSleep Holdings Inc

Actions
  • Price (USD)0.0243
  • Today's Change0.002 / 8.00%
  • Shares traded24.43m
  • 1 Year change+440.00%
  • Beta-1.9095
Data delayed at least 15 minutes, as of Jan 27 2022 19:50 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.34m
  • Incorporated2007
  • Employees6.00
  • Location
    REMSleep Holdings Inc2202 N. WEST SHORE BLVD SUITE 200TAMPA 33607United StatesUSA
  • Phone+1 (912) 590-2001
  • Websitehttps://www.remsleep.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Brain Scientific Inc705.81k-3.11m17.57m--------24.90-0.16-0.160.0351-0.31914.34155.7970.44---1,912.36-989.46----35.00---440.16-627.840.021-148.15----11.26---326.83------
Sigyn Therapeutics Inc-4.59k-2.62m18.01m4.001.0449.51----0.46590.4659-0.00020.0098-0.0045-------255.25-180.91-----------573.520.6393-4.080.6565---100.00--61.98------
Inspira Technologies Oxy BHN Ltd-100.00bn-100.00bn18.09m12.00--1.36----------1.71----------------------------0.0482-------57.99------
PetVivo Holdings Inc14.92k-2.96m19.52m0.00--2.28--1,308.01-0.4057-0.40570.00210.87840.0028-------55.58-217.42-82.71---3.22-336.90-19,818.16-117,831.907.75-2.240.005--250.42-30.03-69.14------
InspireMD Inc3.27m-14.67m20.27m45.00--0.535--6.19-10.43-10.430.71114.690.11252.544.2672,733.34-50.41-90.50-56.52-144.942.1417.43-448.33-309.2410.47--0.00---33.221.47-5.02--40.63--
REMSleep Holdings Inc0.00-4.34m21.74m6.00--17.18-----0.0092-0.00920.000.00140.00-------319.96-1,001.97-1,334.43----------2.11-0.16480.2036------69.77--28.87--
Vivos Inc14.89k-2.65m22.09m10.00--15.45--1,483.61-0.0084-0.00840.000050.00420.0142-------252.33-3,717.80-956.97---37.68---17,808.06-92,615.39---97.450.1719---26.32-21.9140.56------
ReShape Lifesciences Inc10.52m-27.80m22.59m2.00--0.2836--2.15-3.06-3.061.364.480.20492.426.095,259,500.00-54.16-65.93-63.71-83.5463.0637.62-264.28-471.543.33-35.120.0362---51.60-17.0347.91--4.23--
NanoVibronix Inc1.01m-12.81m23.10m11.00--2.58--22.87-0.523-0.5230.04330.32050.14673.0415.4291,818.18-186.14-156.74-195.07-219.1653.3748.84-1,268.71-1,138.2234.68-0.72830.00--17.5533.4925.37--14.87--
Bone Biologics Corp0.00-1.89m23.28m1.00---------0.648-0.6480.00-1.230.00----0.00-6,879.34-1,275.08---------------0.8182--------46.72------
Bioelectronics Corp1.69m-627.34k24.18m9.00------14.31-0.00002-0.000020.00007-0.00063.715.696.49---137.53-366.61----52.4354.72-37.12-160.390.0571-2.00-----11.91-18.7350.13------
Aethlon Medical, Inc.923.04k-8.81m24.48m10.00--1.06--26.52-0.6513-0.65130.06731.500.0474--7.5792,304.00-45.29-110.96-47.99-129.89-----955.13-1,609.98---8,995.130.00--1.37-5.76-23.73--45.10--
Positron Corp1.24m-1.27m24.94m22.00------20.16-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Arch Therapeutics Inc11.57k-6.24m25.51m10.00------2,204.63-0.0283-0.02830.00005-0.00430.0040.0255--1,157.00-214.17-137.70-361.38-170.11-127.14---53,936.82-242,716.801.49-519.582.79-------33.02------
Data as of Jan 27 2022. Currency figures normalised to REMSleep Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

0.06%Per cent of shares held by top holders
HolderShares% Held
North Star Asset Management, Inc.as of 30 Sep 2021575.00k0.06%
IFP Advisors, Inc.as of 31 Dec 20210.000.00%
Data from 30 Sep 2021 - 31 Dec 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.